First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
Lin Shen(Hangzhou Normal University), Lin Xie, Wenxiang Dai(First Affiliated Hospital of University of South China), Hongming Pan, Yi Ba(Tianjin Medical University Cancer Institute and Hospital), Zengqing Guo(Fujian Provincial Cancer Hospital), Futong Zhang(First Hospital of Shijiazhuang), Hao Liu(National University of Defense Technology), Jia Wei(North Sichuan Medical University), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Fu(Nanchang University), Wensheng Qiu(Qingdao University), Zhenghua Wang(Affiliated Hospital of Jining Medical University), Mulin Liu(National Yang Ming Chiao Tung University), Peng Nie(Huawei Technologies (China)), Lian Liu(Qilu Hospital of Shandong University), Yusheng Wang(Shanxi Provincial Cancer Hospital), Jian Chen(Fudan University), Xiangyu Gao(Shenyang Agricultural University), Yuan Yuan(Xuzhou Central Hospital), Wei Li(Fujian Medical University), Ming Liu(Sichuan University), Ning Li(Regeneron (United States)), Zheng Liu(Tongji Hospital), Bo Liu(Shandong Tumor Hospital), Jun Guo(Hebei Medical University), Ziyu Li(Peking University), Jingdong Zhang(Liaoning Cancer Hospital & Institute), Changzheng Li(Henan Medical University), Weibo Wang(Tianjin University), Jun Zhao, Jinhong Xu, Ruixing Zhang(Hebei Medical University), Yifu He(Anhui Provincial Hospital), Xiaotian Zhang(Peking University), Yuansong Bai(First Bethune Hospital of Jilin University), Lili Sheng(First Affiliated Hospital of Wannan Medical College), Xuehong Zhao(Xian Central Hospital), Hongyan Xu(Weihai Municipal Hospital), Bangwei Cao(Capital Medical University), Zhenyang Liu(Qingdao University), Guowu Wu(Meizhou City People's Hospital), Huiting Xu(Weihai Municipal Hospital), Ye Chen(First Affiliated Hospital of Henan University of Science and Technology), Yanqiao Zhang(Harbin Medical University), Nong Xu(First Affiliated Hospital Zhejiang University), Lixin Wan(Nanyang Institute of Technology), Mingzhu Huang(Shanghai Medical College of Fudan University), Xizhi Zhang(People's Hospital of Kaizhou District), Kangsheng Gu(Anhui Medical University)
Cited by 89
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA
|Cell Research|2011|1.2k
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
|Molecular Cancer|2020|1k
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
|Nature|2021|687
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657